「ag」の検索結果
41件：6～10件目を表示
-
quarters: Osaka, Japan; President: Mr. Shuhei Yoshida; hereinafter: Senju) is developing a TRPV1 antagonist (development code: SJP-0132) discovered by Mochida Pharmaceutical Co., Ltd. (Head office: To...
https://www.senju.co.jp/system/files/content_news/2025-01/ENG_20250117.pdf -
vative. BAC is widely used in eye drops but it is known to occasionally cause corneal epithelial damage1. Our goal was to develop a formulation that maintains the efficacy of the previous formulation ...
https://www.senju.co.jp/system/files/content_news/2025-09/ENG_20250904.pdf -
March 7, 2025 General Announcement Senju Pharmaceutical Co., Ltd. Announcement of Licensing Agreement with Brill International Senju Pharmaceutical Co., Ltd. (Headquarters: Osaka, Japan; President: Mr...
https://www.senju.co.jp/system/files/content_news/2025-03/ENG_20250307.pdf -
ロメワン
用すること。 ─ 1 ─ 耳科 Staphylococcus intermedius Pseudomonas aeruginosa Staphylococcus Streptococcus equi agglomerans Acinetobacter lwoffii Enterobacter Streptococcus canis ▲最新の添付文書 ⑶本剤は定められた用法・用量を厳守すること。なお、 ...
https://www.senju.co.jp/system/files/2025-07/lomewon_202504_096-016.pdf -
March 7, 2025 General Announcement Senju Pharmaceutical Co., Ltd. Announcement of Licensing Agreement with Brill International Senju Pharmaceutical Co., Ltd. (Headquarters: Osaka, Japan; President: Mr...
https://www.senju.co.jp/system/files/content_news/2025-03/ENG_20250307_0.pdf